Co-Diagnostics Reports Third Quarter 2025 Financial Results

Tremonton Archived • November 13, 2025 •

SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial results for the…

Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original

FB X ✉️

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!